Market Research Assistance
- + 1-888-391-5441
- [email protected]
On the Web 
Diseases & treatment Market Research Reports
- Cancer Drugs
- Diabetes Drugs
- Mental Illness Drugs
- Cardiovascular Disease Drugs
- Hypertension Drugs
- Inflammation Drugs
- Allergy Drugs
- Central Nervous System Drugs
- Neurology Drugs
- Asthma Drugs
- Hepatitis Drugs
- Arthritis Drugs
- Osteoporosis Drugs
- Tuberculosis Drugs
- Malaria Drugs
- Alzheimer Drugs
- Parkinson Disease Drugs
- HIV
- Multiple Sclerosis Drugs
- Autoimmune Drugs
- Insomnia Drugs
- Obesity Drugs
- Gaucher Drugs
- Anemia Drugs
- Crohn Drugs
- Huntington Drugs
- Paget Drugs
Diseases & treatment Market Research Reports
| Title | published | price | |
|---|---|---|---|
Colitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 UpdateBy Global Markets Direct "...... y Players, 2022 Update, provides an overview of the Colitis (Gastrointestinal) pipeline landscape.
Colitis is swelling (inflammation) of the large intestine (colon). Colitis can have many different causes, including infections, including......" | 31-Mar-2022 | $2000 | |
Diarrhea Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 UpdateBy Global Markets Direct "...... Key Players, 2022 Update, provides an overview of the Diarrhea (Gastrointestinal) pipeline landscape.
Diarrhea is a contagious gastrointestinal infection occurring mostly due to unhygienic conditions. Diarrhea may be related to a viral o......" | 31-Mar-2022 | $2000 | |
Functional (Non Ulcer) Dyspepsia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 UpdateBy Global Markets Direct "...... by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update, provides an overview of the Functional (Non Ulcer) Dyspepsia (Gastrointestinal) pipeline landscape.
Non-ulcer dyspepsia is a term used to describe signs and sympto......" | 31-Mar-2022 | $2000 | |
Reflux Esophagitis (Gastroesophageal Reflux Disease) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 UpdateBy Global Markets Direct "...... l Reflux Disease) - Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update, provides an overview of the Reflux Esophagitis (Gastroesophageal Reflux Disease) (Gastrointestinal) pipeline landscape.
Whe......" | 31-Mar-2022 | $2000 | |
Atypical Hemolytic Uremic Syndrome (Nondiarrhea - Associated Hemolytic Uremic Syndrome) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 UpdateBy Global Markets Direct "...... Atypical Hemolytic Uremic Syndrome - Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update, provides an overview of the Atypical Hemolytic Uremic Syndrome (Gastrointestinal) pipeline landscape.
Atyp......" | 31-Mar-2022 | $2000 | |
Global Osteoarthritis Pain Drugs Market Research Report 2021 - Impact of COVID-19 on the MarketBy Maia Research "...... SD in 2021, and will reach xx Million USD in 2026, with a CAGR of xx during 2021-2026.
Considering the influence of COVID-19 on the global Osteoarthritis Pain Drugs market, this report analyzed the impact from both global and regional ......" | 31-Mar-2022 | $3000 | |
Non Alcoholic Fatty Liver Disease (NAFLD) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 UpdateBy Global Markets Direct "...... ugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update, provides an overview of the Non Alcoholic Fatty Liver Disease (NAFLD) (Gastrointestinal) pipeline landscape.
Nonalcoholic fatty liver disease (NA......" | 31-Mar-2022 | $2500 | |
Non-Alcoholic Steatohepatitis (NASH) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 UpdateBy Global Markets Direct "...... elopment by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update, provides an overview of the Non-Alcoholic Steatohepatitis (NASH) (Gastrointestinal) pipeline landscape.
Non-alcoholic steatohepatitis (NASH) is liver infla......" | 31-Mar-2022 | $2500 | |
Prader-Willi Syndrome (PWS) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 UpdateBy Global Markets Direct "...... , Target, MoA, RoA, Molecule Type and Key Players, 2022 Update, provides an overview of the Prader-Willi Syndrome (PWS) (Genetic Disorders) pipeline landscape.
Prader-Willi Syndrome (PWS) is a rare genetic disorder present at birth that ......" | 31-Mar-2022 | $2000 | |
Iron Deficiency Anemia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 UpdateBy Global Markets Direct "...... MoA, RoA, Molecule Type and Key Players, 2022 Update, provides an overview of the Iron Deficiency Anemia (Hematological Disorders) pipeline landscape.
Anemia is a condition in which the body does not have enough healthy red blood cells. ......" | 31-Mar-2022 | $2000 | |
| | |||